Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve With reference to our intimation dated 05th February, 2026 under Regulation 29 of the SEBI (LODR)Regulations, 2015 regarding Board Meeting to be held on Thursday, 12th February ,2026 for approval of Un-Audited Financial Results of the Company for the Quarter ended December 31st, 2025. This is to inform you thatdue to the unavailability of the auditor, who is currently unable to provide the Limited Review Report , the saidBoard Meeting has been postponed and rescheduled to be held on Saturday, 14th February, 2026.